Clinical & Experimental Cardiology
Open Access

Survival of 101 year old woman on statin therapy

Joint Event on 3^rd International Conference on Cardiovascular Medicine and Cardiac Surgery & 26^th Annual Conference on Clinical & Medical Case Reports in Cardiology

July 05-06, 2018 | Berlin, Germany

William E Feeman

The Bowling Green Study, USA

Scientific Tracks Abstracts: J Clin Exp Cardiolog

Abstract :

Background: Treatment of the elderly patients with dyslipidemia remains controversial with concerns about drug safety in the very old patient population. Objective: To report the course of a 102 year old woman who survived a severe myocardial infarction at age 75 years and has remained clinically free of atherothrombotic disease while receiving statin therapy for those 27 years and no other intervention. Methods: Case report covering one individual over 27 years. Results: The 102 year old woman survived for 27 years following a severe myocardial infarction while receiving statin/antihypertensive therapy and aspirin therapy, but no other intervention. Conclusion: This report supports the literature for statin treatment of dyslipidemia in the very old population to maintain a clinical disease free state following an acute myocardial infarction. The safety of such therapy is also recorded. This report supports the effectiveness of optimal medical therapy in such patients. Overview: The question of how best to treat dyslipidemia in the very old population remains unsettled, though most researchers would favor statin therapy. Concerns have been raised as to drug safety in the very old population. This report follows an elderly female survivor of an acute myocardial infarction at age 75 years, over the next 27 years, to an age of 102 years, on optimal medical therapy. No surgical interventions have been necessary. This report supports the concept of aggressive medical therapy in the very old.